Abstract:It is critical to understand how human quiescent long-term hematopoietic stem cells (LT-HSCs) sense demand from daily and stress-mediated cues and then transition into bioenergetically active progeny to differentiate and meet these cellular needs. However, the demand-adapted regulatory circuits of these early steps of hematopoiesis are largely unknown. Here we show that lysosomes, sophisticated nutrient-sensing and signaling centers, are regulated dichotomously by transcription factor EB (TFEB) and MYC to balance catabolic and anabolic processes required for activating LT-HSCs and guiding their lineage fate. TFEB-mediated induction of the endolysosomal pathway causes membrane receptor degradation, limiting LT-HSC metabolic and mitogenic activation, promoting quiescence and self-renewal, and governing erythroid-myeloid commitment. In contrast, MYC engages biosynthetic processes while repressing lysosomal catabolism, driving LT-HSC activation. Our study identifies TFEB-mediated control of lysosomal activity as a central regulatory hub for proper and coordinated stem cell fate determination.

What problem does this paper attempt to address?

This paper aims to explore how lysosomal activity controls the fate of human long - term hematopoietic stem cells (LT - HSCs) through the dual regulation of transcription factor EB (TFEB) and MYC. Specifically, the research focuses on the following aspects: 1. **The role of lysosomes in LT - HSC activation**: The paper explores how lysosomes, as complex nutrient - sensing and signaling centers, balance catabolism and anabolism in cellular metabolic processes through the dual regulation of TFEB and MYC, thereby affecting the activation and differentiation fate of LT - HSCs. 2. **TFEB regulation of lysosomal activity**: Research shows that TFEB can induce the endolysosomal pathway, leading to the degradation of membrane receptors (such as transferrin receptor 1, TfR1), limiting the metabolic and proliferative activation of LT - HSCs, promoting their quiescent state and self - renewal ability, and determining erythroid/myeloid fate selection. 3. **The competitive relationship between MYC and TFEB**: The paper reveals that MYC drives the activation of LT - HSCs by participating in the biosynthesis process while inhibiting lysosomal catabolism. And the competitive binding of TFEB and MYC in the chromatin region may explain their opposite roles in regulating the metabolic state and fate determination of LT - HSCs. 4. **Lysosomal activity regulation of LT - HSC lineage specification**: The research also explores the differences in the lineage - commitment potential of LT - HSC subpopulations with different lysosomal activity levels, especially that LT - HSCs with higher lysosomal activity show lower TfR1 surface expression levels, which is related to the selection of erythroid cell fate. In summary, the core problem that this paper attempts to solve is: how lysosomal activity regulates the quiescent state, self - renewal ability and lineage specification of human LT - HSCs through the interaction of TFEB and MYC.

TFEB-mediated endolysosomal activity controls human hematopoietic stem cell fate